‘Chemobrain’ linked to disrupted brain networks
Patients who experience ‘chemobrain’ following treatment for breast cancer show disruptions in brain networks that are not present in patients who do not report cognitive difficulties, according to School of Medicine researchers.
Washington People: Jennifer Ivanovich
Cancer genetic counselor Jennifer Ivanovich helps bridge the gap between what genome sequencing can tell patients and what patients and their families want to know.
Staying ahead of Huntington’s disease
Huntington’s disease is a devastating, incurable disorder that results from the death of certain neurons in the brain. Rohit Pappu, PhD, and colleagues in the engineering and medical schools are conducting studies to learn from nature’s own strategies to battle the disease.
Diabetes drugs affect hearts of men, women differently
Widely used treatments for type 2 diabetes have different effects on the hearts of men and women, even as the drugs control blood sugar equally well in both sexes, according to researchers at the School of Medicine. The investigators used PET scans to measure heart and whole-body metabolism in patients taking common diabetes drugs. Pictured are researchers Janet B. McGill, MD, and Robert J. Gropler, MD.
Medical Campus students showcase musical talents
Students from the School of Medicine and Division of Biology & Biomedical Sciences recently shared their musical talents at the fall coffeehouse at the Farrell Learning and Teaching Center. Coffeehouses are hosted by the School of Medicine Arts Commission. Shown are Charise Garber (on piano) and her sister, Kristen Garber.
New models of drug-resistant breast cancer point to better treatments
Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research led by Matthew J. Ellis, MD, PhD, from Washington University School of Medicine in St. Louis.
Rare gene variants double risk for Alzheimer’s disease
A team led by researchers at the School of Medicine has identified variations in a gene that double a person’s risk of developing Alzheimer’s disease later in life. Pictured are Carlos Cruchaga, PhD (left), and Alison M. Goate, DPhil, who led the research effort.
Mohanakumar receives clinical science award
Thalachallour Mohanakumar, PhD, the Jacqueline G. and William E. Maritz Professor of Surgery at the School of Medicine, has received the Paul I. Terasaki Clinical Science Award. He was given the award Nov. 20 at the 39th annual meeting of the American Society for Histocompatibility and Immunogenetics in Chicago.
Study aims to boost safety in construction
Ann Marie Dale, PhD, (right) of the School of Medicine has conducted studies to evaluate methods to reduce injuries construction workers suffer at work. She currently is studying whether participatory ergonomics can lessen such injuries. She is shown here with Lisa Jaegers (left), also of the School of Medicine, and Fritz Hoffmeister, safety director of C&R Mechanical Co., at the Shriners Hospitals for Children-St. Louis construction site.
Annual art show accepting submissions
The School of Medicine’s 10th Annual Art Show is accepting submissions from students, faculty and staff. The art show will be held in the Farrell Learning and Teaching Center atrium from Jan. 21 through Feb. 21.
Older Stories